Volume 19, Issue 4 (July - August 2020)
Payesh 2020, 19(4): 467-468 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Behboudi E, Hamidi-Sofiani V. CD147: A missing key in the corona virus disease-2019 (COVID-19). Payesh 2020; 19 (4) :467-468
URL: http://payeshjournal.ir/article-1-1401-en.html
URL: http://payeshjournal.ir/article-1-1401-en.html
1- Golestan University of Medical Sciences, Gorgan, Iran
Abstract: (3282 Views)
No abstract available
(Letter to editor)
(Letter to editor)
Received: 2020/07/13 | Accepted: 2020/07/14 | ePublished ahead of print: 2020/07/15 | Published: 2020/09/5
References
1. Gu J, Han B, Wang J. COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission. Gastroenterology 2020;158:1518-9 [DOI:10.1053/j.gastro.2020.02.054]
2. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Medicine 2020;46:586-90 [DOI:10.1007/s00134-020-05985-9]
3. The Human Protein Atlas. Proteinatlas.Org. 2020. Available from: http://www.proteinatlas.org/. Accessed 15 July 2020.
4. Zhu X, Song Z, Zhang S, Nanda A, Li G. CD147: a novel modulator of inflammatory and immune disorders. Current Medicinal Chemistry 2014;21:2138-45 [DOI:10.2174/0929867321666131227163352]
5. Yurchenko V, O'Connor M, Dai WW, Guo H, Toole B, Sherry B, Bukrinsky M. CD147 is a signaling receptor for cyclophilin B. Biochemical and Biophysical Research Communications 2001;288:786-8 [DOI:10.1006/bbrc.2001.5847]
6. Wang K, Chen W, Zhou YS, et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. BioRxiv preprint 2020 doi: 10.1101/2020.03.14.988345. [DOI:10.1101/2020.03.14.988345]
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |